SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Director/PDMR Shareholding

20 May 2022 10:20

RNS Number : 2633M
Rentokil Initial PLC
20 May 2022
Β 

Rentokil Initial plc (the Company)

The Company hereby announces that it has been notified that in respect of the final dividend for 2021, the following persons discharging managerial responsibility have acquired ordinary shares of 1 pence in the Company as detailed below as a result of their participation in the Company's Dividend Reinvestment Plan (DRIP). The shares were purchased on 19 May 2022 at Β£4.897230 each.

Name

Number of DRIP shares acquired

Vanessa Evans

2

Stuart Ingall-Tombs

1,270

Alain Moffroid

2,105

John Myers

3,034

Andy Ransom

755

Β 

The notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation and give further detail.

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Vanessa Evans

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Group HR Director

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Rentokil Initial plc

b)

Β 

LEI

Β 

549300VN4WV7Z6T14K68

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary shares of 1p each

Β 

Β 

ISIN: GB00B082RF11

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Acquisition of shares through the Company's

Dividend Reinvestment Plan (DRIP).

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Β£4.897230

2

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Total price

Β 

Β 

Β 

2 shares

Β 

Β£9.79

e)

Β 

Date of the transaction

Β 

19 May 2022

f)

Β 

Place of the transaction

Β 

London Stock Exchange (XLON)

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Stuart Ingall-Tombs

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Chief Financial Officer

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Rentokil Initial plc

b)

Β 

LEI

Β 

549300VN4WV7Z6T14K68

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary shares of 1p each

Β 

Β 

ISIN: GB00B082RF11

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Acquisition of shares through the Company's

Dividend Reinvestment Plan (DRIP).

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Β£4.897230

1,270

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Total price

Β 

Β 

Β 

1,270 shares

Β 

Β£6,219.48

e)

Β 

Date of the transaction

Β 

19 May 2022

f)

Β 

Place of the transaction

Β 

London Stock Exchange (XLON)

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Alain Moffroid

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Managing Director, Europe

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Rentokil Initial plc

b)

Β 

LEI

Β 

549300VN4WV7Z6T14K68

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary shares of 1p each

Β 

Β 

ISIN: GB00B082RF11

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Acquisition of shares through the Company's

Dividend Reinvestment Plan (DRIP).

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Β£4.897230

2,105

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Total price

Β 

Β 

Β 

2,105 shares

Β 

Β£10,308.67

e)

Β 

Date of the transaction

Β 

19 May 2022

f)

Β 

Place of the transaction

Β 

London Stock Exchange (XLON)

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

John Myers

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Managing Director, North America

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Rentokil Initial plc

b)

Β 

LEI

Β 

549300VN4WV7Z6T14K68

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary shares of 1p each

Β 

Β 

ISIN: GB00B082RF11

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Acquisition of shares through the Company's

Dividend Reinvestment Plan (DRIP).

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Β£4.897230

3,034

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Β 

3,034 shares

Β 

Β£14,858.20

e)

Β 

Date of the transaction

Β 

19 May 2022

f)

Β 

Place of the transaction

Β 

London Stock Exchange (XLON)

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Andy Ransom

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Chief Executive

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Rentokil Initial plc

b)

Β 

LEI

Β 

549300VN4WV7Z6T14K68

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary shares of 1p each

Β 

Β 

ISIN: GB00B082RF11

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Acquisition of shares through the Company's

Dividend Reinvestment Plan (DRIP).

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Β£4.897230

755

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Total price

Β 

Β 

Β 

755 shares

Β 

Β£3,697.41

e)

Β 

Date of the transaction

Β 

19 May 2022

f)

Β 

Place of the transaction

Β 

London Stock Exchange (XLON)

Β 

Enquiries:

Β 

Catherine Stead, Company Secretary Rentokil Initial plc 07826533700

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHGCGDUIBDDGDG
Date   Source Headline
29th Aug 20187:00 amRNSDirector/PDMR Shareholding
20th Aug 201812:44 pmRNSDirector/PDMR Shareholding
1st Aug 20183:12 pmRNSHolding(s) in Company
31st Jul 20187:00 amRNSInterim Results
27th Jul 20185:07 pmRNSHolding(s) in Company
5th Jul 20184:52 pmRNSHolding(s) in Company
5th Jul 201811:36 amRNSDirector Declaration
28th Jun 20184:10 pmRNSHolding(s) in Company
7th Jun 20185:16 pmRNSDirector Declaration
17th May 20184:12 pmRNSDirector/PDMR Shareholding
16th May 20187:00 amRNSNotice of Capital Markets Days
9th May 20185:40 pmRNSResult of AGM
4th May 20184:27 pmRNSDirector/PDMR Shareholding
2nd May 201810:52 amRNSDirector/PDMR Shareholding
1st May 20186:00 pmRNSDirector/PDMR Shareholding
30th Apr 20185:48 pmRNSDirector/PDMR Shareholding
26th Apr 20183:24 pmRNSHolding(s) in Company
25th Apr 20184:50 pmRNSHolding(s) in Company
24th Apr 20183:55 pmRNSHolding(s) in Company
24th Apr 201810:53 amRNSHolding(s) in Company
20th Apr 20184:09 pmRNSDirector/PDMR Shareholding
19th Apr 20184:32 pmRNSHolding(s) in Company
19th Apr 20187:00 amRNSQ1 Trading Update
5th Apr 201812:57 pmRNSHolding(s) in Company
5th Apr 201811:06 amRNSAnnual Financial Report
4th Apr 20186:01 pmRNSDirector/PDMR Shareholding
3rd Apr 20184:12 pmRNSBlock listing Interim Review
29th Mar 201811:55 amRNSTotal Voting Rights
27th Mar 20184:01 pmRNSHolding(s) in Company
27th Mar 201812:58 pmRNSAdditional Listing
8th Mar 20185:50 pmRNSDirector/PDMR Shareholding
1st Mar 20187:00 amRNSFinal Results
27th Dec 20177:00 amRNSDirector/PDMR Shareholding
20th Dec 20173:40 pmRNSDirector/PDMR Shareholding
22nd Nov 20174:30 pmRNSHolding(s) in Company
17th Nov 20177:00 amRNSIssue of new EUR400m bond
13th Nov 20174:35 pmRNSHolding(s) in Company
13th Nov 20177:00 amRNSPurchase of Vector Disease Acquisition LLC
7th Nov 20174:14 pmRNSHolding(s) in Company
6th Nov 20177:00 amRNSDirectorate Change
2nd Nov 20176:07 pmRNSHolding(s) in Company
1st Nov 20177:00 amRNSDirectorate Change
19th Oct 20177:00 amRNSQ3 Trading Update
2nd Oct 20173:26 pmRNSBlock listing Interim Review
21st Sep 20177:00 amRNSDirectorate Change
18th Sep 20177:00 amRNSDirectorate Change
22nd Aug 20173:34 pmRNSChange to Director's details
4th Aug 201711:57 amRNSDirector/PDMR Shareholding
31st Jul 20172:16 pmRNSDirector Declaration
27th Jul 20177:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.